anti-cd20 antibody Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (2)

Phase 2 (2)

Interventional (2)

Chinese University of Hong Kong (1)
The University of Hong Kong (1)

No (2)

No (2)

Adult (18+) (2)
Pediatric (Under 18) (1)

I am/have/had

I am/have/hadtesticular

I am/have/hadhematopoietic stem cell transplantation

I am/have/hadenzyme-linked immunosorbent assay

I am/have/hadimmunoglobulins

I am/have/hadimmunoglobulin

I am/have/hadflow cytometry

I am/have/hadmucosal biopsy

I am/have/hadindirect immunofluorescence

I am/have/hadpemphigus

I am/have/hadremission

I am/have/hadcns involvement

I am/have/hadleukemic cells

I am/have/hadb-cell acute lymphoblastic leukemia

I am/have/hadleukemia

I am/have/haddirect immunofluorescence

I am/have/hadacute lymphoblastic leukemia

I am/have/hadelisa

I am/have/hadautoimmune disease

I am/have/hadacantholysis

added new label for I am/have/had

more

I am looking for

I am looking forbortezomib injection

I am looking forimmunoglobulin

I am looking forrituximab

I am looking forimmunoglobulins

I am looking forigiv

I am looking forimmunoglobulin g

I am looking forcorticosteroids

I am looking forprednisolone

I am looking fortositumomab

I am looking foranti-cd20 antibody

I am looking forimmunomodulators

I am looking forproteasome inhibitor

I am looking forimmunosuppressants

I am looking forpediatric

I am looking forintravenous immunoglobulin

I am looking forimmunosuppressive agents

added new label for I am looking for

more

Advanced Filters

Loading...

Found 2 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For pediatric ages
For adults
Recruiting in 100s
Interventional Study
all
Recruiting

CCCG Relapsed Acute Lymphoblastic Leukemia 2017 Study in Children

New agents will be added aiming at improving survival outcome. Study of adding anti-CD20 antibody (rituximab) with chemotherapy: CD20 is found to be expressed in 40-50% of B-lineage ALL, and rituximab has been studied in adult ALL with superior survival (75% vs 47%,).

bortezomib injection

remission

testicular

cns involvement

leukemic cells

0 views
19 Feb, 2024

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Dermatology
Recruiting

IVIG With Rituximab vs Rituximab as First Line Treatment of Pemphigus

A recent randomized trial has proved the efficacy of Rituximab, a monoclonal anti-CD20 antibody against B-lymphocytes, as an efficacious therapy for pemphigus. Early use of rituximab was associated with better clinical outcomes, hence combination treatment of rituximab and intravenous immunoglobulins (IVIG) has shown to be effective for refractory pemphigus cases …

enzyme-linked immunosorbent assay

rituximab

immunoglobulins

immunoglobulin

igiv

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.